ArticleBlood advances2022

Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.

Zhiyu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.